Business Wire - Biovail Reports Record Fourth Quarter and Full Year 2002 Financial Results
November 17th, 2008 Business Editors/Health/Medical Writers
TORONTO–(BUSINESS WIRE)–March 4, 2003
– Total revenue increased 34% for fourth quarter 2002 and 35% for full year 2002
– Excluding certain charges, 2002 diluted EPS was $1.77 reflecting an increase of 31%
Biovail Corporation (NYSE:BVF)(TSX:BVF) today reported record financial resul…
Mixing Heart Drugs Can Be Fatal For Some!
November 10th, 2008A standard combination of diuretics and blood-pressure drugs has been prescribed to heart-failure patients by their doctors. Such treatment has widely been used in United States following a research conducted in 1999 reporting that the medicines reduced deaths by 3…
Despite Expiring Patents, High Drug Prices May Persist
November 9th, 2008Aug. 18, 2000 (Washington) — With America on the verge of the largest cycle of drug-patent expirations in the nation’s history, analysts remain decidedly divided on what benefit, if any, consumers will enjoy from this unprecedented trend.
Over the next four year…
Myocarditis - Causes, Symptoms and Treatment Methods
November 6th, 2008Myocarditis is an inflammation of the myocardium, the thick muscular layer of the heart wall. It is an uncommon disorder that is usually caused by viral infections such as coxsackie virus, adenovirus, and echovirus. It may …
Lotrel - Everything You Need to Know
November 1st, 2008If you are suffering with high blood pressure problems, no doubt you are also looking at various medications as a solution. It is very likely you have come across the drug Lotrel, but how much do you really know about it? On the one ha…
Blood Pressure Combo Lowers Risk of Stroke
October 27th, 2008Sept. 27, 2001 — Stroke is the No. 3 cause of death in the U.S. and leaves many more people severely disabled. But now doctors may have a way to prevent this crippling medical problem.
High blood pressure is one of the leading reasons th…
Business Wire - Biovail Reports Record Second Quarter 2002 Results
October 23rd, 2008 Business & Health/Medical Editors
TORONTO–(BW HealthWire)–July 25, 2002
Biovail Corporation (NYSE:BVF) (TSX:BVF)
- Revenues increased 39% for the quarter to $185.1 million -
- Second quarter diluted EPS of $0.39
increased 30% versus prior…
American Family Physician - Using ACE inhibitors appropriately - Clinical Pharmacology
October 22nd, 2008Cardiovascular disease affects one in four Americans. According to the American Heart Association, heart and related diseases are expected to cost Americans more than $329 billion in 2002. An estimated 10 million persons in this country are known to have diabetes and 3.6 million to have renal disease, incurring annual health care costs of $98 billion and $11 billion, respectively. Although angiotensin-conver…
Keeping Seniors Independent
October 15th, 2008March 14, 2002 — Treating older women with high blood pressure medications known as ACE inhibitors may do more than keep their blood pressure in check. A new study suggests the drugs may also help preserve muscle strength and prevent disability.
“This is one of the first studies …
M2 Presswire - Market Commentary on Merck & Co. Inc.
October 11th, 2008M2 PRESSWIRE-28 June 2007-Biotech News: Market Commentary on Merck & Co. Inc(C)1994-2007 M2 COMMUNICATIONS LTD RDATE:28062007 Market Commentary on Merck & Co. Inc (NYSE:MRK) Merck & Co., Inc. engages in the discovery, development, manufacture, and marketing of various products for human and animal health.
Related Results
…


